Skip to main content
. 2022 Oct 2;29(1):106–114. doi: 10.1111/hae.14668

TABLE 1.

Characteristics of HCV antibody‐positive persons with inherited bleeding disorders at their last clinical evaluation

Spontaneous clearance Ever diagnosed with chronic HCV
Number 73 309 a
Total number of follow‐up years 2944 12,839
Median follow‐up (years) 41 (35–50) 44 (34–50)
Male sex 71 (97%) 297 (96%)
Diagnosis
Haemophilia A 54 (74%) 250 (81%)
Haemophilia B 11 (15%) 42 (14%)
Von Willebrand disease 6 (8%) 8 (3%)
Other b 2 (3%) 9 (3%)
Severe bleeding disorder 53 (73%) 234 (76%)
Age at HCV infection (years) 6 (1–22) 8 (2–18)
Age at end of follow‐up (years) 51 (40–63) 52 (43–63)
HCV genotype
1 c 178 (58%)
2 29 (9%)
3 26 (8%)
4 7 (2%)
5 2 (1%)
Unknown 73 (100%) 67 (22%)
HIV infection 7 (10%) 48 (16%)
HBV infection
HBsAg positive 4 (6%) 6 (2%)
HBsAg negative, anti‐HBc positive 23 (32%) 122 (40%)
History of severe alcohol use d 5 (7%) 37 (12%)
Body Mass Index (kg/m2) 26 (24–28) 25 (22–27)
At least advanced fibrosis e 2 (3%) f 110 (36%)
Child–Pugh A/B/C 1/1/0 74/26/10
Alanine transaminase (IU/L) 22 (16–27) 28 (18–52)
Aspartate transaminase (IU/L) 24 (20–29) 26 (18–43)
Platelet count (*109/L) 236 (208–304) 215 (156–262)
Bilirubin (μmol/L) 10 (7–13) 11 (8–16)
Albumin (g/L) 42 (38–43) 42 (38–45)
International normalised ratio 1.0 (1.0–1.1) 1.0 (1.0–1.1)

Data are number (percentage) or median (interquartile range) unless otherwise noted. Anti‐HBc, hepatitis B core antibodies; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus.

a

One individual spontaneously cleared HCV after >20 years of chronic infection.

bDeficiency factor II (n = 1), VII (n = 1), X (n = 4), XIII (n = 2), or haemophilia carrier (n = 2).

cSubtypes: 1a n = 53, 1a/b n = 5, 1b n = 74, 1c n = 1, unknown n = 45.

dAlcohol intake > 20 units/week.

eFibroscan ≥ 9.5 kPa or radiological, histological or clinical diagnosis.

fBoth were diagnosed with alcoholic cirrhosis.